- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03938077
A Community-University Approach to Preventing HIV
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48109
- University of Michigan
-
Flint, Michigan, United States, 48504
- YOUR Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 16-21 years of age
- Sexually Active
- African American
- Live in Flint Michigan
Exclusion Criteria:
- Report of prior psychiatric hospitalization by adolescent
- Visible cognitive impairment due to drug use
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: S4E App intervention
Youth will receive the S4E intervention via provided iPads. The intervention will last approximately 60. Content includes: (a) storytelling scenarios, (b) drug use and HIV/STI knowledge, (c) interactive activities, (d) increasing self-efficacy to prevent/reduce sexual and drug use risk behaviors and increase HIV self-testing, (e) Near Peer-youth communication, and (f) highlighting prevention principles. The youth will participate in a Near Peer-initiated prevention and risk reduction encounter which includes (a) reinforcement of HIV solutions that youth learned in the S4E app, (b) promotion of HIV self-tests, and (c) linkage to care and prevention services. Youth have the option to take a HIV self-test. We will determine the acceptability of youth disclosing their results to their Near Peer and linkage to resources. The research staff will also conduct in-depth qualitative interviews with both youth and Near Peer participants to assess feasibility and acceptability of S4E. |
S4E application was developed in collaboration with youth in Southeast Michigan.
S4E aims to prevent and reduce HIV/STI risk behaviors, including drug use and sexual risk behaviors, and increase HIV testing among youth.
Content produced for the application is based on scientific prevention principles in conjunction with youth input.
To date, we have developed modules focused on youth alcohol & drug use, HIV & STIs, and tobacco prevention and cessation.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Lifetime HIV Testing
Time Frame: Baseline
|
At baseline we will assess binary outcome of participant's lifetime HIV testing and collect date of most recent HIV test using an item adapted from the Centers for Disease Control (CDC) Youth Behavior Risk Survey (YRBS).
A sample question for youth is "Have you every been tested for HIV?".
Responses consist of "1=Yes", "0=No", and "98=Refuse to Answer".
|
Baseline
|
HIV Self-Testing
Time Frame: Immediately post-intervention
|
Immediately post-intervention, we will assess the binary outcome of HIV self-testing using items adopted from Lightfoot and colleagues (2018).
|
Immediately post-intervention
|
HIV Self-Test Results Disclosure
Time Frame: Immediately post-intervention
|
Post-intervention we will asses the percentage of youth that disclose their HIV self-test results to the Near Peer.
|
Immediately post-intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Sexual Risk Beliefs from baseline to immediately post-intervention
Time Frame: baseline and immediatly post-intervention
|
Beliefs regarding sexual behaviors (e.g., intended sex, condom use, and other contraceptives) will be assessed.
A sample question for the youth is, "Condoms help prevent pregnancy."
Responses range from "1=Strongly disagree" to "5=Strongly Agree".
|
baseline and immediatly post-intervention
|
Change in Sexual Risk Attitudes from baseline to immediately post-intervention
Time Frame: baseline and immediatly post-intervention
|
Attitudes about sexual behaviors (e.g., intended sex, condom use, and other contraceptives) will be assessed.
A sample question for the youth is "If I used a condom, sex would not feel as good."
Responses range from "1=Strongly disagree" to "5=Strongly Agree".
|
baseline and immediatly post-intervention
|
Change in Future intentions regarding sexual risk from baseline to immediately post-intervention
Time Frame: baseline and immediatly post-intervention
|
Change in future intentions of sexual behaviors (e.g., intended sex, condom use, and other contraceptives) will be assessed.
A sample question for the youth is, "How likely is it that you will decide to have sex in the next 90 days?"." Responses range from "1=Very Unlikely" to "5=Very Likely".
|
baseline and immediatly post-intervention
|
Linkage to Care and Prevention
Time Frame: immediately post-intervention
|
The percent of youth who are referred to substance use, mental health, and sexual health services will be assessed.
|
immediately post-intervention
|
Eligibility rates for the Near Peer
Time Frame: enrollment period pre-intervention
|
During the recruitment period of Near Peers, we will monitor and record the percentage of potential near peer participants who meet eligibility criteria to be enrolled in the study.
|
enrollment period pre-intervention
|
Percent of Enrollment for Near Peer
Time Frame: enrollment period pre-intervention
|
During the recruitment period of Near Peers, we will monitor and record the percentage of those potential near peers eligible to participate who decide to enroll in the study.
|
enrollment period pre-intervention
|
Intervention Completion Rates for Near Peer
Time Frame: immediately-post intervention
|
Immediately post intervention we will assess the rate of intervention completion of Near Peers.
|
immediately-post intervention
|
Eligibility rates for the Youth
Time Frame: enrollment period pre-intervention
|
Immediately post-intervention, we will assess the percentage of participants who meet eligibility criteria for our study.
|
enrollment period pre-intervention
|
Percent of Enrollment for Youth
Time Frame: enrollment period pre-intervention
|
We will assess the percentage of those youth eligible to participate who are enrolled in the study.
|
enrollment period pre-intervention
|
Intervention Completion Rates for Youth
Time Frame: immediately post-intervention
|
Immediately post intervention, we will assess the rate of intervention completion of youth participants.
|
immediately post-intervention
|
Near Peer Satisfaction of the S4E app: Client Satisfaction Questionnaire (CSQ)
Time Frame: immediately-post intervention
|
Satisfaction is defined as how much the Near Peer enjoyed using the app and will be measured by the Client Satisfaction Questionnaire (CSQ).
The CSQ is a eight item survey adapted from Larsen and colleagues (1979) that has been shown to be reliable and valid, and was previously used in a primary care intervention (Cordova et al., 2018).
In our previous studies the alphas have ranged from 0.87 to 0.92.
A sample question is "How would you rate the app you have received?".
Responses range from "1=Poor" to "4=Excellent".
|
immediately-post intervention
|
Acceptability of S4E Session for Near Peer: Session Evaluation Form (SEF)
Time Frame: immediately-post intervention
|
Acceptability is defined as how much the Near Peer enjoyed the intervention and will be measured by the Session Evaluation Form (SEF).
The SEF is a 13-item survey, modified from Harper and colleagues (2008), that has been shown to be reliable and valid, and was previously used in a primary care intervention (Cordova et al., 2018).
In our previous studies the alpha of SEF was 0.89.
A sample question is "The session was enjoyable".
Responses range from "1=Strongly Agree" to "4=Strongly Disagree".
|
immediately-post intervention
|
Youth Satisfaction of the S4E app: Client Satisfaction Questionnaire (CSQ
Time Frame: immediately-post intervention
|
Satisfaction is defined as how much the youth enjoyed using the app and will be measured by the Client Satisfaction Questionnaire (CSQ).
The CSQ is a eight item survey adapted from Larsen and colleagues (1979) that has been shown to be reliable and valid, and was previously used in a primary care intervention (Cordova et al., 2018).
In our previous studies the alphas have ranged from 0.87 to 0.92.
A sample question is "How would you rate the app you have received?".
Responses range from "1=Poor" to "4=Excellent".
|
immediately-post intervention
|
Acceptability of S4E Session for Youth: Session Evaluation Form (SEF)
Time Frame: immediately-post intervention
|
Acceptability is defined as how much the youth enjoyed the interview session and will be measured by the Session Evaluation Form (SEF).
The SEF is a 13-item survey, modified from Harper and colleagues (2008), that has been shown to be reliable and valid, and was previously used in a primary care intervention (Cordova et al., 2018).
In our previous studies the alpha of SEF was 0.89.
A sample question is "The session was enjoyable".
Responses Range from "1=Strongly Agree" to "4=Strongly Disagree".
|
immediately-post intervention
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Near Peer-Youth Communication for Near Peers from baseline to immediately post-intervention
Time Frame: baseline and immediately post-intervention
|
Completed by the Near Peer, Near Peer-youth communication will be assessed post-baseline using items adapted from the Matched Pair Instrument (19 items; MPI). MPI assesses process and content of communication, including verbal and action-related behaviors performed by Near Peers. Responses range from "1=strongly disagree," to "5=strongly agree," on a five-point Likert scale. A sample statement for Near Peers and youths is, " I encouraged the youth to express his or her thoughts concerning drug use behaviors." The Adolescent Patient-Provider Interaction Scale will also be used to assess Near Peer- youth interaction for accessing sexual and reproductive health care (e.g., the Near Peer explained everything youth needed to know). |
baseline and immediately post-intervention
|
Change in Near Peer-Youth Communication for Youth from baseline to immediately post-intervention
Time Frame: baseline and immediately post-intervention
|
Completed by the youth, Near Peer-youth communication will be assessed post-baseline using items adapted from the Matched Pair Instrument (19 items; MPI). MPI assesses process and content of communication, including verbal and action-related behaviors performed by Near Peers. Responses range from "1=strongly disagree," to "5=strongly agree," on a five-point Likert scale. A sample statement for Near Peers and youths is, "I was encouraged to express my thoughts concerning drug use behaviors." The Adolescent Patient-Provider Interaction Scale will also be used to assess Near Peer- youth interaction for accessing sexual and reproductive health care (e.g., the Near Peer explained everything youth needed to know). |
baseline and immediately post-intervention
|
Change in Youth Self-Efficacy as measured by Drug Use Resistance Self-Efficacy Scale from baseline to immediately post-intervention
Time Frame: baseline and immediately post-intervention
|
Youth's self-efficacy will be assessed using two scales, including the Condom Self-Efficacy Scale (19 items, α =.85), and Drug Use Resistance Self-Efficacy (24 items, α =.98).
Responses range from "1=not sure at all," to "4=definitely sure," on a four-point Likert scale.
A sample question for the youth is, "How sure are you that you can refuse if a friend offers you marijuana at a party and you do not want it?"
|
baseline and immediately post-intervention
|
Change in Youth Self-Efficacy as measured by the Condom Self-Efficacy Scale from baseline to immediately post-intervention
Time Frame: baseline and immediately post-intervention
|
Youth's self-efficacy will be assessed using two scales, including the Condom Self-Efficacy Scale (19 items, α =.85), and Drug Use Resistance Self-Efficacy (24 items, α =.98).
Responses range from "1=not sure at all," to "4=definitely sure," on a four-point Likert scale.
A sample question for the youth is, "How sure are you that you can refuse if a friend offers you marijuana at a party and you do not want it?"
|
baseline and immediately post-intervention
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: David Cordova, PhD, University of Michigan
Publications and helpful links
General Publications
- Cordova D, Alers-Rojas F, Lua FM, Bauermeister J, Nurenberg R, Ovadje L, Fessler K, Delva J, Salas-Wright CP, Council YL. The Usability and Acceptability of an Adolescent mHealth HIV/STI and Drug Abuse Preventive Intervention in Primary Care. Behav Med. 2018 Jan-Mar;44(1):36-47. doi: 10.1080/08964289.2016.1189396. Epub 2016 Jul 15.
- Cordova D, Bauermeister JA, Fessler K, Delva J, Nelson A, Nurenberg R, Mendoza Lua F, Alers-Rojas F, Salas-Wright CP; Youth Leadership Council. A Community-Engaged Approach to Developing an mHealth HIV/STI and Drug Abuse Preventive Intervention for Primary Care: A Qualitative Study. JMIR Mhealth Uhealth. 2015 Dec 18;3(4):e106. doi: 10.2196/mhealth.4620.
- Cordova D, Lua FM, Ovadje L, Fessler K, Bauermeister JA, Salas-Wright CP, Vaughn MG, Leadership Council Y. Adolescent Experiences of Clinician-Patient HIV/STI Communication in Primary Care. Health Commun. 2018 Sep;33(9):1177-1183. doi: 10.1080/10410236.2017.1339379. Epub 2017 Jul 7.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HUM00151011
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Tobacco Use
-
University of VirginiaVirginia Foundation for Healthy YouthRecruitingTobacco Use | Electronic Cigarette Use | Tobacco Use CessationUnited States
-
Vanderbilt University Medical CenterCompletedTobacco Use | Tobacco Use Cessation
-
Juul Labs, Inc.CompletedTobacco Use | Tobacco Smoking | Electronic Cigarette Use | Cigarette Use, ElectronicUnited States
-
Juul Labs, Inc.CompletedTobacco Use | Tobacco Smoking | Electronic Cigarette Use | Cigarette Use, ElectronicUnited States
-
Mayo ClinicNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, Tobacco | Smoking, CigaretteUnited States
-
Claremont Graduate UniversityNational Cancer Institute (NCI)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, CigaretteUnited States
-
British American Tobacco (Investments) LimitedCompletedTobacco Use | Tobacco SmokingUnited States
-
Washington University School of MedicineNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Nicotine Dependence | Tobacco Dependence | Smoking, Tobacco | Nicotine Use Disorder | Nicotine Dependence, Cigarettes | Smoking, Cigarette | Nicotine Dependence Tobacco Product | Tobacco; Use, Rehabilitation | Smoking (Tobacco) Addiction and other conditionsUnited States
-
Johns Hopkins UniversityNational Institute on Drug Abuse (NIDA)RecruitingTobacco Use | Tobacco Smoking | Tobacco Use Disorder | Tobacco Use Cessation | Tobacco DependenceUnited States
-
Philip Morris Products S.A.CompletedSmoking | Tobacco Use | Tobacco SmokingUnited Kingdom
Clinical Trials on Storytelling 4 Empowerment
-
Institute of Population, Health and Development...University of Massachusetts, WorcesterCompleted
-
Istituto Auxologico ItalianoEuropean UnionCompleted
-
University of PittsburghIcahn School of Medicine at Mount SinaiCompletedSurrogate Decision Maker, After Death of PatientUnited States
-
University of Colorado, DenverNational Institute of Nursing Research (NINR)CompletedHeart Failure | Cancer | COPDUnited States
-
Arizona State UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...Not yet recruitingHealth Knowledge, Attitudes, Practice | COVID-19 Pandemic | Vaccine-Preventable Diseases | Health-Related Behavior | NarrationUnited States
-
Vanderbilt University Medical CenterFriends in Global HealthActive, not recruitingHIV InfectionsMozambique
-
University Hospital FreiburgStanford University; Heidelberg UniversityNot yet recruitingPsychological Capital
-
University of Alabama at BirminghamVanderbilt University Medical CenterRecruiting
-
Azienda Per I Servizi Sanitari N. 2 IsontinaAzienda per i servizi Sanitari 4 Medio Friuli, Dipartimento di Salute Mentale... and other collaboratorsCompletedObesity | Overweight | Power, PersonalItaly